Wed, January 23, 2013
Tue, January 22, 2013
Mon, January 21, 2013
Fri, January 18, 2013
Thu, January 17, 2013
Wed, January 16, 2013
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013
Thu, January 10, 2013
Wed, January 9, 2013
Tue, January 8, 2013
[ Tue, Jan 08th 2013 ] - Market Wire
Cambridge Heart Provides Update
Mon, January 7, 2013
Sun, January 6, 2013
Fri, January 4, 2013
Thu, January 3, 2013
Wed, January 2, 2013
Mon, December 31, 2012
Fri, December 28, 2012
Thu, December 27, 2012
Wed, December 26, 2012
[ Wed, Dec 26th 2012 ] - Market Wire
30 p.m. ET
Mon, December 24, 2012
Fri, December 21, 2012
Thu, December 20, 2012
[ Thu, Dec 20th 2012 ] - Market Wire
A View from the Top
Wed, December 19, 2012

Law Office of Brodsky amp;; Smith, LLC Announces Investigation of Epocrates, Inc.


//health-fitness.news-articles.net/content/2013/ .. lc-announces-investigation-of-epocrates-inc.html
Published in Health and Fitness on Monday, January 7th 2013 at 20:00 GMT by Market Wire   Print publication without navigation


Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates,... -- BALA CYNWYD, Pa., Jan. 7, 2013 /PRNewswire/ --

BALA CYNWYD, Pa., Jan. 7, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq: [ EPOC ]) relating to the proposed acquisition by AthenaHealth, Inc. ("AthenaHealth").

Under the terms of the transaction, Epocrates shareholders will receive only $11.75 in cash for each share of Epocrates stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Epocrates for not acting in the Company's shareholders' best interests in connection with the sale process to AthenaHealth. The transaction may undervalue the Company and will result in a loss for many shareholders. For example Epocrates stock traded at $25.80 as recently as March 15, 2011. In addition, an analyst has set a price target for Epocrates stock at $15.00 per share and the Epocrates app is used by approximately 338,000 U.S. physicians.

If you own shares of Epocrates stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ] visiting [ http://brodsky-smith.com/526-epoc-epocrates-inc.html ], by calling toll free 877-LEGAL-90.

SOURCE Brodsky & Smith, LLC



RELATED LINKS
[ http://www.brodsky-smith.com ]

Publication Contributing Sources